Benzinga
@Benzinga
Financial News, Data & Education 💸
가입 June 2009
850 팔로잉 중 343.9K 팬
Kodiak Sciences ($KOD) says Zenkuda and tabirafusp-ted matched Regeneron’s ($REGN) Eylea in a Phase 3 wet AMD trial.
Zenkuda also showed durable vision gains, with 54% of patients maintaining improvement for six months.
더 보기
